A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.
- Vitamin D regulates calcium in intestine differently than previously thought
- More evidence that cellular ‘death by iron’ could be promising avenue of cancer treatment
- Glucosamine may reduce overall death rates as effectively as regular exercise
- After 100 years, Cornell University plant pathologists revisit fire blight hypothesis
- COVID-19 may deepen depression, anxiety, and PTSD among pregnant and postpartum women